Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hervé Lebrec

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Toxicologic Pathology|November 4, 2017
Immunophenotyping: Application to Safety AssessmentXiaoting Wang, Hervé Lebrec
Journal of Applied Toxicology : JAT|July 1, 2010
Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cellsHervé Lebrec, Padma Narayanan, Raymond Nims
Journal of Immunotoxicology|February 4, 2012
A summary of meeting proceedings for 'Measuring immune responses in non-human primates for drug development-opportunities and challenges for predicting human efficacy and immunotoxicity'Cris Kamperschroer, Amitinder Kaur, Hervé Lebrec
Journal of Immunotoxicology|October 29, 2021
Application of a newly-developed cynomolgus macaque BiTE-mediated cytotoxic T-lymphocyte activity assay to various immunomodulatory agents <i>in vitro</i>Brendon Frank, Hao Guo, Hervé Lebrec, et al.
Journal of Immunotoxicology|November 9, 2011
Survey: immune function and immunotoxicity assessment in dogsHervé Lebrec, Raegan O'Lone, Wendy Freebern, et al.
Journal of Immunotoxicology|September 9, 2022
Strategies to evaluate potential effector function of glycan variants: a case study of ordesekimab (AMG 714 or PRV-015)Yu-Ling Wei, Teresa Wegesser, Scott Kuhns, et al.
Journal of Immunotoxicology|February 27, 2020
Summary of a workshop on preclinical and translational safety assessment of CD3 bispecificsCris Kamperschroer, Jacintha Shenton, Hervé Lebrec, et al.
Journal of Biomolecular Screening|June 9, 2006
Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometryJon R Inglefield, Christopher J Larson, Sheila J Gibson, et al.
Current Medical Research and Opinion|February 5, 2015
Tumor necrosis factor, tumor necrosis factor inhibition, and cancer riskHervé Lebrec, Rafael Ponce, Bradley D Preston, et al.
Journal of Immunotoxicology|September 23, 2018
Development of a BiTE<sup>®</sup>-mediated CD8<sup>+</sup> cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaqueBrendon Frank, Yu-Ling Wei, Kyung-Hoon Kim, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Toxicologic Pathology|November 4, 2017
Immunophenotyping: Application to Safety AssessmentXiaoting Wang, Hervé Lebrec
Journal of Applied Toxicology : JAT|July 1, 2010
Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cellsHervé Lebrec, Padma Narayanan, Raymond Nims
Journal of Immunotoxicology|February 4, 2012
A summary of meeting proceedings for 'Measuring immune responses in non-human primates for drug development-opportunities and challenges for predicting human efficacy and immunotoxicity'Cris Kamperschroer, Amitinder Kaur, Hervé Lebrec
Journal of Immunotoxicology|October 29, 2021
Application of a newly-developed cynomolgus macaque BiTE-mediated cytotoxic T-lymphocyte activity assay to various immunomodulatory agents <i>in vitro</i>Brendon Frank, Hao Guo, Hervé Lebrec, et al.
Journal of Immunotoxicology|November 9, 2011
Survey: immune function and immunotoxicity assessment in dogsHervé Lebrec, Raegan O'Lone, Wendy Freebern, et al.
Journal of Immunotoxicology|September 9, 2022
Strategies to evaluate potential effector function of glycan variants: a case study of ordesekimab (AMG 714 or PRV-015)Yu-Ling Wei, Teresa Wegesser, Scott Kuhns, et al.
Journal of Immunotoxicology|February 27, 2020
Summary of a workshop on preclinical and translational safety assessment of CD3 bispecificsCris Kamperschroer, Jacintha Shenton, Hervé Lebrec, et al.
Journal of Biomolecular Screening|June 9, 2006
Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometryJon R Inglefield, Christopher J Larson, Sheila J Gibson, et al.
Current Medical Research and Opinion|February 5, 2015
Tumor necrosis factor, tumor necrosis factor inhibition, and cancer riskHervé Lebrec, Rafael Ponce, Bradley D Preston, et al.
Journal of Immunotoxicology|September 23, 2018
Development of a BiTE<sup>®</sup>-mediated CD8<sup>+</sup> cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaqueBrendon Frank, Yu-Ling Wei, Kyung-Hoon Kim, et al.
Pageof 2